» Articles » PMID: 38419895

A Newly Synthesized Flavone Avoids COMT-catalyzed Methylation and Mitigates Myocardial Ischemia/reperfusion Injury in H9C2 Cells Via JNK and P38 Pathways

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Luteolin is a flavone that provides defense against myocardial ischemia/reperfusion (I/R) injury. However, this compound is subjected to methylation mediated by catechol-O-methyltransferase (COMT), thus influencing its pharmacological effect. To synthesize a new flavone from luteolin that avoids COMT-catalyzed methylation and find out the protective mechanism of LUA in myocardial I/R injury.

Materials And Methods: Luteolin and 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH) were used to synthesize the new flavone known as LUAAPH-1 (LUA). Then, the myocardial ischemia/reperfusion injury cell model was established using H9c2 cells to detect the effect in myocardial ischemia/reperfusion regulation and to identify the underlying mechanism.

Results: Pretreatment with LUA (20 μmol/l) substantially increased cell viability while reducing cell apoptosis rate and caspase-3 expression induced by I/R, and the protective effect of LUA on cell viability was stronger than diosmetin, which is the major methylated metabolite of luteolin. In addition, intracellular reactive oxygen species (ROS) production and calcium accumulation were both inhibited by LUA. Furthermore, we identified that LUA markedly relieved the promotive effects of I/R stimulation upon JNK and p38 phosphorylation.

Conclusion: LUT pretreatment conveys significant cardioprotective effects after myocardial I/R injury, and JNK and p38 MAPK signaling pathway may be involved.

Citing Articles

Magea13 attenuates myocardial injury in acute myocardial infarction by inhibiting the cAMP-PKA signaling pathway.

Zheng J, Xu X, Zhang Z, Ge K, Xiang Y, Dai H Apoptosis. 2025; .

PMID: 40056358 DOI: 10.1007/s10495-025-02078-0.

References
1.
Li H, Xia Z, Chen Y, Qi D, Zheng H . Mechanism and Therapies of Oxidative Stress-Mediated Cell Death in Ischemia Reperfusion Injury. Oxid Med Cell Longev. 2018; 2018:2910643. PMC: 6035842. DOI: 10.1155/2018/2910643. View

2.
Chen Y, Liu C, Zhou P, Li J, Zhao X, Wang Y . Coronary Endothelium No-Reflow Injury Is Associated with ROS-Modified Mitochondrial Fission through the JNK-Drp1 Signaling Pathway. Oxid Med Cell Longev. 2021; 2021:6699516. PMC: 7878075. DOI: 10.1155/2021/6699516. View

3.
Gonzalez-Montero J, Brito R, Gajardo A, Rodrigo R . Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities. World J Cardiol. 2018; 10(9):74-86. PMC: 6189069. DOI: 10.4330/wjc.v10.i9.74. View

4.
Wang L, Chen Q, Zhu L, Li Q, Zeng X, Lu L . Metabolic Disposition of Luteolin Is Mediated by the Interplay of UDP-Glucuronosyltransferases and Catechol-O-Methyltransferases in Rats. Drug Metab Dispos. 2016; 45(3):306-315. PMC: 6041822. DOI: 10.1124/dmd.116.073619. View

5.
Zhai M, Li B, Duan W, Jing L, Zhang B, Zhang M . Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis. J Pineal Res. 2017; 63(2). DOI: 10.1111/jpi.12419. View